COMPARISON OF PERGOLIDE AND BROMOCRIPTINE THERAPY IN PARKINSONISM

被引：114

作者：

LEWITT, PA

WARD, CD

LARSEN, TA

RAPHAELSON, MI

NEWMAN, RP

FOSTER, N

DAMBROSIA, JM

CALNE, DB

机构：

[1] NINCDS,OFF BIOMETRY & FIELD STUDIES,BETHESDA,MD 20205

[2] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20205

来源：

关键词：

D O I：

10.1212/WNL.33.8.1009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1009 / 1014

页数：6

共 38 条

[1] [Anonymous], 1978, ERGOT ALKALOIDS RELA
[2] BURNS RS, 1981, APOMORPHINE OTHER DO, V2, P93
[3] CALNE DB, 1978, LANCET, V1, P735
[4] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS
CORRODI, H
FUXE, K
HOKFELT, T
LIDBRINK, P
UNGERSTEDT, U
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) : 409 - 412
[5] DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313
[6] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS
GOLDSTEIN, M
LIEBERMAN, A
LEW, JY
ASANO, T
ROSENFELD, MR
MAKMAN, MH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3725 - 3728
[7] FIBROTIC DISORDERS ASSOCIATED WITH METHYSERGIDE THERAPY FOR HEADACHE
GRAHAM, JR
SUBY, HI
LECOMPTE, PR
SADOWSKY, NL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (07) : 359 - &
[8] 2-PERIOD CROSSOVER CLINICAL-TRIAL
HILLS, M
ARMITAGE, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) : 7 - 20
[9] DIFFERENCES IN DOPAMINERGIC EFFECTS OF ERGOT DERIVATIVES BROMOCRIPTINE, LISURIDE AND D-LSD AS COMPARED WITH APOMORPHINE
HOROWSKI, R
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (02) : 157 - 166
[10] ILSON J, 1982, NEUROLOGY, V32, pA181